Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

This study is ongoing, but not recruiting participants.

Study NCT00527124 Information provided by Barbara Ann Karmanos Cancer Institute

First Received: September 7, 2007 Last Updated: January 23, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	July 2012 (Final data collection date for primary outcome measure)